Association of obstructive sleep apnea risk with asthma control in adults

Chest

Volumn 138, Issue 3, 2010, Pages 543-550

  Teodorescu, Mihaela ^a   Polomis, David A ^a   Hall, Stephanie V ^a   Teodorescu, Mihai C ^a   Gangnon, Ronald E ^a   Peterson, Andrea G ^a   Xie, Ailiang ^a   Sorkness, Christine A ^a,b   Jarjour, Nizar N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IPRATROPIUM BROMIDE; THEOPHYLLINE; RESPIRATORY TRACT AGENT;

ADULT; ARTICLE; ASTHMA; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RHINITIS; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TERTIARY HEALTH CARE; ADOLESCENT; AGED; BODY MASS; COHORT ANALYSIS; COMPLICATION; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; BODY MASS INDEX; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RESPIRATORY SYSTEM AGENTS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 77956819376     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-3066     Document Type: Article

References (50)

1. US Department of Health and Human Services;National Institutes of Health;National Heart, Lung and Blood Institute; National Asthma Education and Prevention Program. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. Full report 2007. http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.pdf. Accessed August 15, 2009.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org/Guidelineitem.asp?l1=2&l2=1&intId= 1561. Accessed August 15, 2009.
3. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Rev ed. http://www.brit-thoracic.org.uk/Portals/0/Clinical%20Information/Asthma/ Guidelines/asthma-final2008.pdf. Accessed August 15, 2009.
4. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: the GOAL study. Eur Respir J. 2007;29(1): 56-62.
5. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166(8):1044-1049.
6. Lai CK, De Guia TS, Kim YY, et al; Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma control in the Asia-Pacific region:the Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol. 2003;111(2): 263-268.
7. Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis. 1988;137(6):1502-1504.
8. Guilleminault C, Quera-Salva MA, Powell N, et al. Nocturnal asthma:snoring, small pharynx and nasal CPAP. Eur Respir J. 1988;1(10):902-907.
9. Ciftci TU, Ciftci B, Guven SF, Kokturk O, Turktas H. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med. 2005;99(5):529-534.
10. Lafond C, Sériès F, Lemière C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J. 2007;29(2):307-311. (Pubitemid 46231908)
11. Boulet LP, Hamid Q, Bacon SL, et al. Symposium on obesity and asthma-November 2, 2006. Can Respir J. 2007;14(4): 201-208.
12. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26(5):812-818.
13. Woolcock A, Rubinfeld AR, Seale JP, et al. Thoracic Society of Australia and New Zealand. Asthma management plan, 1989. Med J Aust. 1989;151(11-12):650- 653.
14. Guidelines for management of asthma in adults:I - Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ. 1990; 301(6753):651-653.
15. Lemière C, Bai T, Balter M, et al; Canadian Adult Consensus Group of the Canadian Thoracic Society. Adult Asthma Consensus Guidelines update 2003. Can Respir J. 2004; 11(suppl A):9A-18A.
16. Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616-621.
17. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902-907.
18. Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553-558.
19. Douglass AB, Bornstein R, Nino-Murcia G, et al. The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. Sleep. 1994;17(2):160-167.
20. Hall SV, Sorkness CA, Peterson AG, et al. Association of obstructive sleep apnea (OSA) symptoms and asthma control. Am J Respir Crit Care Med. 2008;177(abstract suppl):A671.
21. Teodorescu M, Hall SV, Peterson AG, et al. Do shorter and full versions of the Asthma Control Questionnaire have similar correlations with obstructive sleep apnea risk? Sleep. 2008;31(abstract suppl):A307.
22. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease(COPD)and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis. 1987;136(1):225-244.
23. Auckley D, Moallem M, Shaman Z, Mustafa M. Findings of a Berlin Questionnaire survey:comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med. 2008;9(5):494-499.
24. Teodorescu M, Peterson AG, Teodorescu MC, et al. Airway inflammation in asthma patients with obstructive sleep-disordered breathing (oSDB). Am J Respir Crit Care Med. 2009;179(abstract suppl):A2874.
25. Zanation AM, Senior BA. The relationship between extraesophageal reflux (EER) and obstructive sleep apnea (OSA). Sleep Med Rev. 2005;9(6):453-458.
26. Harding SM. Gastroesophageal reflux:a potential asthma trigger. Immunol Allergy Clin North Am. 2005;25(1):131-148.
27. Bijaoui EL, Champagne V, Baconnier PF, Kimoff RJ, Bates JH. Mechanical properties of the lung and upper airways in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2002;165(8):1055-1061.
28. Ballard RD. Sleep, respiratory physiology, and nocturnal asthma. Chronobiol Int. 1999;16(5):565-580.
29. Lin CC, Lin CY. Obstructive sleep apnea syndrome and bronchial hyperreactivity. Lung. 1995;173(2):117-126.
30. Nadel JA, Widdicombe JG. Effect of changes in blood gas tensions and carotid sinus pressure on tracheal volume and total lung resistance to airflow. J Physiol. 1962;163 :13-33.
31. D'Brot J, Ahmed T. Hypoxia-induced enhancement of nonspecific bronchial reactivity:role of leukotrienes. J Appl Physiol. 1988;65(1):194-199.
32. Eckert DJ, Catcheside PG, Stadler DL, McDonald R, Hlavac MC, McEvoy RD. Acute sustained hypoxia suppresses the cough reflex in healthy subjects. Am J Respir Crit Care Med. 2006;173(5):506-511.
33. Eckert DJ, Catcheside PG, Smith JH, Frith PA, McEvoy RD. Hypoxia suppresses symptom perception in asthma. Am J Respir Crit Care Med. 2004;169(11):1224-1230.
34. Mehra R, Redline S. Sleep apnea: a proinflammatory disorder that coaggregates with obesity. J Allergy Clin Immunol. 2008;121(5):1096-1102. (Pubitemid 351626934)
35. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002;122(4):1162-1167. (Pubitemid 35339525)
36. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003;124(4):1386-1392.
37. Salerno FG, Carpagnano E, Guido P, et al. Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med. 2004;98(1):25-28.
38. Li AM, Hung E, Tsang T, et al. Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea. Thorax. 2007;62(1):75-79.
39. Foley SC, Hamid Q. Images in allergy and immunology: neutrophils in asthma. J Allergy Clin Immunol. 2007;119(5): 1282-1286.
40. Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther. 2006;110(1):83-102.
41. van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy. 2008;63(5):570-574.
42. Komakula S, Khatri S, Mermis J, et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res. 2007;8:32.
43. Todd DC, Armstrong S, D'Silva L, Allen CJ, Hargreave FE, Parameswaran K. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts. Clin Exp Allergy. 2007;37(7):1049-1054.
44. Sutherland TJ, Cowan JO, Young S, et al. The association between obesity and asthma:interactions between systemic and airway inflammation. Am J Respir Crit Care Med. 2008; 178(5):469-475.
45. Kryger MH, Roth T, Dement WC. Principles and Practice of Sleep Medicine. Philadelphia, PA:Elsevier;2005:603-608.
46. Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra-and infratentorial strokes. A prospective study of 39 patients. Stroke. 1997;28(9): 1765-1772.
47. Weatherwax KJ, Lin X, Marzec ML, Malow BA. Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire(SA-SDQ)is a useful screening instrument for obstructive sleep apnea in a disease-specific population. Sleep Med. 2003;4(6):517-521.
48. Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest. 2009;136(3):772-778.
49. Knuiman M, James A, Divitini M, Bartholomew H. Longitudinal study of risk factors for habitual snoring in a general adult population: the Busselton Health Study. Chest. 2006;130(6):1779-1783. (Pubitemid 46033433)
50. Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161(12):1514-1519.